HFD and AngII model of HFpEF

• Metabolic dysfunction in HFpEF refers to systemic metabolic disturbances—such as obesity, insulin resistance, and type 2 diabetes—that contribute to impaired myocardial energetics, increased inflammation, and endothelial dysfunction. These abnormalities exacerbate ventricular stiffness and impaired relaxation.